Tests have indicated that Yale’s Mandi Schwartz is no longer in remission in her battle with acute myeloid leukemia, a development that has postponed her stem cell transplant.
Schwartz needs to be in remission to have the transplant, so she will undergo more chemotherapy.
Her doctors at Fred Hutchinson Cancer Care Center in Seattle have developed what’s being called a breakthrough procedure in the stem cell transplant that is being planned for when Schwartz is again in remission.
For more information, see yalebulldogs.com.
